Key result
Diabetes mellitus confers at least a two-fold increased risk of cardiovascular events, underscoring the critical need for effective antithrombotic strategies to reduce morbidity and mortality.
Why the study?
Cardiovascular disease is the leading cause of death in diabetes mellitus and patients remain at twofold higher cardiovascular risk despite modern cardioprotective therapies, making proper antithrombotic strategies critical.
This review highlights the importance of tailored antithrombotic strategies, including novel agents and combination therapies, to mitigate the high cardiovascular risk and antiplatelet resistance in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Supports tailored antithrombotic strategies in diabetes; leaves open optimal regimens pending dedicated RCTs.
Siasos et al. (2020) conducted a review in Diabetes mellitus. Antithrombotic strategies was evaluated. Diabetes mellitus confers at least a two-fold increased risk of cardiovascular events, underscoring the critical need for effective antithrombotic strategies to reduce morbidity and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: